Tag: FDA bioequivalence

Narrow Therapeutic Index Drugs: Stricter Bioequivalence Requirements Explained

Narrow therapeutic index drugs require tighter bioequivalence standards to prevent dangerous dosing errors. Learn how the FDA, EMA, and Health Canada regulate generics like warfarin and levothyroxine - and why these rules matter for patient safety.